Troy A. Ignelzi - Dec 16, 2022 Form 4 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role
Chief Financial Officer
Signature
/s/ Troy Ignelzi
Stock symbol
KRTX
Transactions as of
Dec 16, 2022
Transactions value $
$109,176
Form type
4
Date filed
12/19/2022, 03:24 PM
Previous filing
Nov 17, 2022
Next filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRTX Common Stock Options Exercise $100K +10.9K +109.02% $9.20* 20.8K Dec 16, 2022 Direct
transaction KRTX Common Stock Options Exercise $3.41K +371 +1.78% $9.20* 21.2K Dec 16, 2022 Direct
transaction KRTX Common Stock Options Exercise $5.77K +627 +2.96% $9.20* 21.8K Dec 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRTX Option (right to buy) Options Exercise $0 -10.9K -8.94% $0.00 111K Dec 16, 2022 Common Stock 10.9K $9.20 Direct F1
transaction KRTX Option (right to buy) Options Exercise $0 -371 -4.15% $0.00 8.56K Dec 16, 2022 Common Stock 371 $9.20 Direct F2
transaction KRTX Option (right to buy) Options Exercise $0 -627 -50.04% $0.00 626 Dec 16, 2022 Common Stock 627 $9.20 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vested and became exercisable as to 1/4th of the shares underlying the option award on March 1, 2020, and continues to vest as to an additional 1/8th of the shares on each six month anniversary thereafter.
F2 This option vested as to 1/36th of the shares underlying the option award on each one month anniversary of the vesting commencement date of March 1, 2019.